In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...
Leaders from the WHO responded with a statement saying that the organization hopes the United States will reconsider. “WHO ...
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...
A panelist discusses how she carefully transitions patients to neurokinin-targeted therapies by establishing realistic timelines for symptom improvement and actively monitoring patient response while ...
Kamilia Smith, MD, FACOG, NCMP, discusses how vasomotor symptoms (VMS) significantly impact sleep quality while examining the evolving landscape of VMS management, including both current treatment ...